Therapy Areas: Hereditary Disorders
Northwestern Medicine's study shows lung transplantation highly effective and successful in critically-ill COVID-19 patients
4 February 2022 -

Healthcare company Northwestern Medicine on Thursday published in the Journal of the American Medical Association (JAMA) the positive outcomes in the first 30 consecutive COVID-19 patients who underwent a lung transplant in Chicago.

The outcomes for the company's COVID-19 lung transplant patients are validated by a concurrent paper in New England Journal of Medicine (NEJM). Dr Ankit Bharat, the company's chief of thoracic surgery, reportedly performed the COVID-19 lung transplant.

Among the 102 consecutive lung transplant recipients from 21 January 2020 to 30 September 2021, about 30 patients were transplanted due to COVID-19 and 72 patients were transplanted due to chronic end-stage lung disease including cystic fibrosis, pulmonary hypertension, idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease, according to the company.

In June 2020, the company's surgeons performed the first lung transplant on a COVID-19 patient in the US. To date, 40 COVID-19 patients have received its lung transplants. For COVID-19 patients with irrecoverable lung damage, transplantation is the only option for survival.



Related Headlines